MOUNTAIN VIEW, Calif., Jan. 8, 2013 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure ® procedure, the leading non-surgical permanent birth control method, today announced that the Company will release 2012 fourth quarter financial results and introduce 2013 full year financial guidance on Tuesday, February 5, 2013, after the close of market. Management will host an investment community conference call beginning at 4:30 p.m. Eastern time on February 5, 2013, to discuss the results and answer questions. Conference call dial-in information is as follows:
- U.S. callers: (866) 428-9517; Password: 87049882
- International callers: (253) 237-1155; Password: 87049882
About Conceptus®, Inc.Conceptus, Inc. is the global leader in the development and commercialization of innovative device-based solutions in permanent birth control. The Company manufactures and markets the Essure Permanent Birth Control System. Please visit www.essure.com for more information on the Essure procedure. Patients may call the Essure Information Center at 1-877-ESSURE-1 with questions or to find a physician in their area. About the Essure ® Procedure The Conceptus, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7961 © 2013 Conceptus, Inc.— All rights reserved.
CONTACT: Investor Relations Contact: Lynn Pieper Westwicke Partners (415) 202-5678 firstname.lastname@example.org